Premium
Carbohydrate‐deficient transferrin is not a useful marker for the detection of chronic alcohol abuse
Author(s) -
Schmitt Um,
P Stieber,
Dieter Jüngst,
Manfred Bilzer,
Martin Wächtler,
Stephan Heberger,
D. Seidel
Publication year - 1998
Publication title -
european journal of clinical investigation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.164
H-Index - 107
eISSN - 1365-2362
pISSN - 0014-2972
DOI - 10.1046/j.1365-2362.1998.00343.x
Subject(s) - carbohydrate deficient transferrin , medicine , alcohol abuse , alcohol , gastroenterology , population , transferrin , radioimmunoassay , psychiatry , biology , alcohol consumption , biochemistry , environmental health
Background The role of carbohydrate‐deficient transferrin (CDT) as a reliable marker for the detection of chronic alcohol abuse has been discussed controversially. Methods Therefore, we investigated CDT in the sera from 405 subjects with different alcohol intake. Besides healthy control subjects ( n = 42), inpatients and outpatients in a department of gastroenterology ( n = 325) and patients admitted to a department of otorhinolaryngology ( n = 38) were studied. A total of 213 patients suffered from various forms of liver diseases, and 89 patients had liver transplantation. CDT values were determined by a double‐antibody radioimmunoassay. Results In the 241 alcohol‐abstinent subjects, CDT levels ranged from 3 to 90 units L −1 (median = 12); the 92 moderate drinkers (20–60 g of alcohol per day) showed values from 3 to 40 units L −1 (median = 12), and the 72 subjects with chronic alcohol abuse (> 60 g per day) revealed CDT levels from 3 to 100 units L −1 (median = 16). The diagnostic specificity for alcohol abuse was 86.8% for men (sensitivity 36.9%) and 95% for women (sensitivity 0%). Conclusion Our data indicate that measurement of CDT does not reach clinical use in the detection of chronic alcohol abuse in an unselected population because of its insufficient specificity and sensitivity.